CVS vs RYAN · P/E 16, rev $402.07B vs P/E 43, rev $2.46B
CVS Health Corp (CVS) versus Ryan Specialty Group Holdings Inc (RYAN) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Ryan Specialty Group Holdings Inc (RYAN) is a insurance - specialty company listed on NYSE.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported RYAN revenue for 2024-12-31 was $2.46B. Net income was $229.9M. Revenue was up 21.2% from 2023-12-31 to 2024-12-31. RYAN currently screens at market cap $9.33B and trailing P/E 43.1.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. RYAN currently screens at market cap $9.33B and trailing P/E 43.1.
Not investment advice. Open the CVS and RYAN stock pages for the full models.
Not investment advice.